Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast‐Food Diet Model-Reference-Cited by-同舟云学术

Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast‐Food Diet Model

Published:2019-06-19 Issue:5 Volume:70 Page:1546-1563
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bhushan Bharat¹^ORCID,Banerjee Swati¹,Paranjpe Shirish¹,Koral Kelly¹,Mars Wendy M.¹^ORCID,Stoops John W.¹,Orr Anne¹,Bowen William C.¹,Locker Joseph¹^ORCID,Michalopoulos George K.¹

Affiliation:

1. Department of Pathology, School of Medicine University of Pittsburgh Pittsburgh PA

Funder

Cleveland Foundation

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30696

Reference30 articles.

1. Burden of liver diseases in the world

2. Pharmacological management of nonalcoholic fatty liver disease

3. Dual Role of Epidermal Growth Factor Receptor in Liver Injury and Regeneration after Acetaminophen Overdose in Mice

4. Hepatostat: Liver regeneration and normal liver tissue maintenance

5. Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kurarinol restrains non-alcoholic fatty liver disease-associated hepatocellular carcinoma (HCC) progression by suppressing EGFR signaling;Journal of Functional Foods;2024-10

2. Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets;Biochemical Pharmacology;2024-09

3. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche;The Journal of Pathology;2024-06-14

4. A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver;2024-01-27

5. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review;Biomedicine & Pharmacotherapy;2024-01